COVID-19:血衍生天然抗凝固剂的一个案例?
Rainer Seitz1, Lutz Gürtler2, Wolfgang Schramm3
1Paul-Ehrlich-Institut, Langen, Germany.
概括
COVID-19 治疗正在探索除了抗体之外的血蛋白. 天然蛋白酶抑制剂,如抗血素III和α-1-抗素,在控制血栓炎症方面显示出潜力,需要进一步研究.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 对COVID-19被动免疫接种的康复性血显示了相互矛盾的结果.
- 严重的COVID-19因血栓炎症而复杂,传统抗凝剂的疗效有限.
- 关键的天然蛋白酶抑制剂 (抗素III,α1-抗素,α2-宏球蛋白) 在严重的COVID-19中减少,并影响原血栓和炎症途径.
研究的目的:
- 探索血蛋白的潜力,超越抗体,用于COVID-19治疗.
- 研究天然蛋白酶抑制剂在COVID-19相关的血栓炎症中的作用.
- 强调需要进一步研究这些抑制剂的诊断,预后和治疗应用.
主要方法:
- 对康复期血,血栓炎症和COVID-19中蛋白酶抑制剂的现有文献的审查.
- 对抗血III (ATIII),α1-抗素 (α1-AT) 和α2-宏球蛋白 (α2-M) 在COVID-19病理生理学中的作用的分析.
- 不同蛋白酶抑制剂的可用性和治疗潜力的比较.
主要成果:
- 关于康复期血对COVID-19的疗效存在相互矛盾的证据.
- 自然蛋白酶抑制剂 (ATIII,α1-AT,α2-M) 在严重的COVID-19中降低,并且在控制血栓炎症方面至关重要.
- 虽然ATIII和α1-AT作为治疗缩剂可用,但α2-M不是.
结论:
- 血蛋白酶抑制剂代表了COVID-19研究和治疗开发的一个有希望的领域.
- 通过蛋白酶抑制剂向血栓炎症可能为基于抗体的疗法提供替代或辅助疗法.
- 对α2-宏球蛋白和其他蛋白酶抑制剂的进一步研究对于临床应用至关重要.
更多相关视频
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
8.3K
06:12Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
Published on: July 21, 2023
594
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
01:16Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
01:22Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K